Spiber has 4 close competitors: BioMason, BioRender, BioLinq.
Sector, valuation and status for each competitor.
A private valuation and a public market cap share one column; each row names its basis and date.
BioMason
BioRender
BioLinq
Formation BioSpiber, Inc. is a Japanese biomaterials company developing structural protein technology, marketed as Brewed Protein fiber, for apparel, lifestyle, beauty, food and healthcare applications.
Spiber competes with 4 companies here: BioMason, BioRender, BioLinq, Formation Bio.
Spiber was last valued at $1.8B . That price was agreed in one transaction and holds until the next round. A listed competitor is repriced every trading session.
No. Spiber is a private company; its shares do not trade on a public exchange.
The last valuation is $1.8B.
Lead investors for each round are in the funding timeline.
The closest biotechnology (structural protein / biomaterials, "brewed protein" fiber) peers are on the competitors page.
Perpetual markets for stocks, gold, indices and pre-IPO names — settled on-chain, no wallet-to-exchange transfers.
